Daily Newsletter

09 August 2023

Daily Newsletter

09 August 2023

ALPINION Medical introduces new ultrasound diagnostic device

The device can operate for 100 hours in standby mode and more than one hour in scan mode using two batteries.

Srivani Venna August 09 2023

ALPINION Medical Systems has introduced the new portable ultrasound diagnostic device, X-CUBE i9.

The device features dual batteries and probe connectors that improve the speed of examinations.

With the flexibility to be ready within one minute, it can operate for 100 hours in standby mode and more than one hour in scan mode using the two batteries.

X-CUBE i9’s dual connector allows easy installation of two types of probes.

It facilitates quick examination in different scenarios such as situations where patient mobility is limited or when scanning multiple body parts is necessary.

Furthermore, the system can be carried easily with its own dedicated cart/carrying bag.

The device is equipped with the X+ MicroView microvascular diagnosis technology that is used in high-performance systems. It also features CUBE Strain technology for analysing heart function.

With real-time needle location visualisation, the Needle Vision Plus feature improves accuracy and stability in ultrasound-guided anaesthesia and nerve block. It also helps enhance diagnosis efficiency through post-processing support after storage.

In addition, the device has a rubber-less integral mould design that helps reduce the damage due to needles.

It also supports a seamless transducer with better durability.

ALPINION CEO Hyun-jong Park said: "Customers have waited for the X-CUBE i9 even before its launching because of their high satisfaction with the image performance. I am expecting various field applications after its launching."

Healthcare companies are hesitant to invest in the metaverse

The COVID-19 pandemic pushed the healthcare industry to rapid digitalization. Increased use of telehealth, telepresence systems, remote diagnostics, predictive AI, and wearable technology is changing how healthcare is delivered and improving patient outcomes. Emerging technologies such as AR and VR are becoming increasingly routine for professional training, surgical assistance, and treatment of psychological and neurological disorders. In the pharma and medical devices industries, AR, VR, and AI are rapidly accelerating drug discovery and manufacturing and generating supply chain efficiencies. New digital opportunities will look to build upon disruptive technologies. However, affordability is a limiting factor to widespread adoption. Per GlobalData estimates, the metaverse market is expected to grow at a CAGR of more than 33% between 2023 and 2030. Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close